Fabino enterprises Ltd. has officially communicated to BSE Limited that it does not fall under the Large Corporate category as defined by SEBI regulations, exempting it from specific disclosure requirements for the upcoming financial year.

Regulatory Disclosure Details

The company filed its initial disclosure on April 11, 2026, confirming its status regarding SEBI's Large Corporate framework. The disclosure specifically addresses the non-applicability of Chapter XII of SEBI Operational circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, along with subsequent updates and revisions.

SEBI Large Corporate Framework

The disclosure references the revised framework as per SEBI Circular no. SEBI/HO/DDHS/DDHS-RACPODI/P/CIR/2023/172 dated October 19, 2023. According to the company's assessment, Fabino Enterprises does not meet the applicability criteria mentioned in Clause 3.2 of the said circular as of March 31, 2026.

Company Status and Compliance

Fabino Enterprises Ltd., formerly known as Fabino Life Sciences Ltd., operates as an ISO 9001:2015 certified company. The regulatory disclosure confirms that the company is not required to file any disclosures under the Large Corporate framework for Financial Year 2026-27.

Management Authorization

The disclosure was digitally signed and submitted by Managing Director Aditya Mahavir Jain on April 11, 2026. The communication was formally addressed to BSE Limited as part of the company's regulatory compliance obligations under Regulation 30.

This disclosure ensures transparency regarding the company's regulatory status and confirms its compliance with SEBI's disclosure requirements for entities that do not fall under the Large Corporate category framework.

Fabino Enterprises Ltd. has filed its quarterly compliance certificate with BSE Limited for the quarter ended March 31, 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission demonstrates the company's adherence to regulatory compliance standards and transparency in shareholder services.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, dated April 10, 2026. This regulation, which replaced the erstwhile Regulation 54 of SEBI (Depository and Participant) Regulations, 1996, requires companies to report on the status of their shareholding dematerialization.

Non-Applicability Status

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, confirmed that Regulation 74(5) is not applicable to Fabino Enterprises Ltd. The non-applicability stems from the complete digitization of the company's shareholding structure, with all shares maintained in dematerialized form.

The certificate specifically states that no requests were received from company members for either rematerialization or dematerialization during the quarter ended March 31, 2026. This indicates a fully digital shareholding base, eliminating the need for physical share certificate management.

Corporate Information

Fabino Enterprises Ltd., formerly known as Fabino Life Sciences Ltd., operates as an ISO 9001:2015 certified company. The submission was signed by Aditya Mahavir Jain, Managing Director, bearing DIN 09353344, and digitally authenticated on April 11, 2026.

The quarterly compliance filing reflects the company's commitment to regulatory adherence and maintains transparency with stakeholders regarding its shareholding structure and transfer agent services.